Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2014, Article ID 656341, 6 pages
http://dx.doi.org/10.1155/2014/656341
Research Article

Duration of Type 2 Diabetes and Very Low Density Lipoprotein Levels Are Associated with Cognitive Dysfunction in Metabolic Syndrome

1Department of Endocrinology and Metabolism, Cleveland Clinic, Cleveland, OH 44195, USA
2Department of Psychology, Kent State University, 238 Kent Hall Addition, Kent, OH 44242, USA

Received 20 January 2014; Accepted 30 May 2014; Published 25 June 2014

Academic Editor: Koichi Hirata

Copyright © 2014 Divya Yogi-Morren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Nathan, “Long-term complications of diabetes mellitus,” The New England Journal of Medicine, vol. 328, no. 23, pp. 1676–1685, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. M. W. J. Strachan, R. M. Reynolds, R. E. Marioni, and J. F. Price, “Cognitive function, dementia and type 2 diabetes mellitus in the elderly,” Nature Reviews Endocrinology, vol. 7, no. 2, pp. 108–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. G. J. Biessels, S. Staekenborg, E. Brunner, C. Brayne, and P. Scheltens, “Risk of dementia in diabetes mellitus: a systematic review,” The Lancet Neurology, vol. 5, no. 1, pp. 64–74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Cukierman, H. C. Gerstein, and J. D. Williamson, “Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies,” Diabetologia, vol. 48, no. 12, pp. 2460–2469, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. W. J. Strachan, I. J. Deary, F. M. E. Ewing, and B. M. Frier, “Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies,” Diabetes Care, vol. 20, no. 3, pp. 438–445, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Kumari and M. Marmot, “Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study,” Neurology, vol. 65, no. 10, pp. 1597–1603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. van den Berg, Y. D. Reijmer, J. DeBresser, R. P. Kessels, L. J. Kappelle, and G.J. Biessels, “A 4-year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus,” Diabetologia, vol. 53, no. 1, pp. 58–65, 2010. View at Google Scholar · View at MathSciNet
  8. M. Vanhanen, K. Koivisto, L. Karjalainen et al., “Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function,” NeuroReport, vol. 8, no. 6, pp. 1527–1530, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. Gold, I. Dziobek, V. Sweat et al., “Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes,” Diabetologia, vol. 50, no. 4, pp. 711–719, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. J. J. Spauwen, S. Köhler, F. R. J. Verhey, C. D. A. Stehouwer, and M. P. J. van Boxtel, “Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht aging study,” Diabetes Care, vol. 36, no. 6, pp. 1554–1561, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Tran, J. Baxter, R. F. Hamman, and J. Grigsby, “Impairment of executive cognitive control in type 2 diabetes, and its effects on health-related behavior and use of health services,” Journal of Behavioral Medicine, vol. 37, no. 3, pp. 414–422, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Cukierman-Yaffe, “Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial,” Diabetes Care, vol. 32, no. 8, article e103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Sommerfield, I. J. Deary, and B. M. Frier, “Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes,” Diabetes Care, vol. 27, no. 10, pp. 2335–2340, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. L. J. Launer, M. E. Miller, J. D. Williamson et al., “Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy,” The Lancet Neurology, vol. 10, no. 11, pp. 969–977, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Lorenzo, M. Okoloise, K. Williams, M. P. Stern, and S. M. Haffner, “The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study,” Diabetes Care, vol. 26, no. 11, pp. 3153–3159, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Cavalieri, S. Ropele, K. Petrovic et al., “Metabolic syndrome, brain magnetic resonance imaging, and cognition,” Diabetes Care, vol. 33, no. 12, pp. 2489–2495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. N. Akbaraly, M. Kivimaki, M. J. Shipley et al., “Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study,” Diabetes Care, vol. 33, no. 1, pp. 84–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. O. Obisesan, “Hypertension and Cognitive Function,” Clinics in Geriatric Medicine, vol. 25, no. 2, pp. 259–288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Whitmer, D. R. Gustafson, E. Barrett-Connor, M. N. Haan, E. P. Gunderson, and K. Yaffe, “Central obesity and increased risk of dementia more than three decades later,” Neurology, vol. 71, no. 14, pp. 1057–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. B. S. Kang and J. S. Yoon, “Sheet forming apparatus with flexible rollers,” PCT Patent pending, 2013.
  21. R. Suzuki, H. A. Ferris, M. J. Chee, E. Maratos-Flier, and C. R. Kahn, “Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function,” PLoS Biology, vol. 11, no. 4, Article ID e1001532, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. S. M. Silverstein, S. Berten, P. Olson et al., “Development and validation of a World-Wide-Web-based neurocognitive assessment battery: WebNeuro,” Behavior Research Methods, vol. 39, no. 4, pp. 940–949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Baddeley, H. Emslie, and I. Nimmo-Smith, “The spot-the-word test: a robust estimate of verbal intelligence based on lexical decision,” British Journal of Clinical Psychology, vol. 32, no. 1, pp. 55–65, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. R. M. Reitan, “Validity of the trail making test as an indicator of organic brain damage,” Perceptual and Motor Skills, vol. 8, no. 3, pp. 271–276, 1958. View at Publisher · View at Google Scholar · View at Scopus
  26. K. W. Walsh, Understanding Brain Damage: A Primer of Neuropsychological Evaluation, Churchill Livingstone, 1985.
  27. L. K. McEvoy, G. A. Laughlin, E. Barrett-Connor et al., “Metabolic syndrome and 16-year cognitive decline in community dwelling older adults,” Annals of Epidemiology, vol. 22, no. 5, pp. 310–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. O'Donnell, K. Teo, P. Gao et al., “Cognitive impairment and risk of cardiovascular events and mortality.,” European Heart Journal, vol. 33, no. 14, pp. 1777–1786, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Basile, A. Crucitti, M. D. Cucinotta et al., “Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure,” Geriatrics & Gerontology International, vol. 13, no. 4, pp. 1035–1042, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. L. Alosco, M. B. Spitznagel, M. van Dulmen et al., “Cognitive function and treatment adherence in older adults with heart failure,” Psychosomatic Medicine, vol. 74, no. 9, pp. 965–973, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Beth Spitznagel, R. Galioto, K. Limbach, J. Gunstad, and L. Heinberg, “Cognitive function is linked to adherence to bariatric postoperative guidelines,” Surgery for Obesity and Related Diseases, vol. 9, no. 4, pp. 580–585, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. A. W. Stitt, “Advanced glycation: An important pathological event in diabetic and age related ocular disease,” British Journal of Ophthalmology, vol. 85, no. 6, pp. 746–753, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Brownlee, “Advanced protein glycosylation in diabetes and aging,” Annual Review of Medicine, vol. 46, pp. 223–234, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. H. S. Park, J. Y. Park, and R. Yu, “Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6,” Diabetes Research and Clinical Practice, vol. 69, no. 1, pp. 29–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Jakobsen, M. Nedergaard, M. Aarslew-Jensen, and N. H. Diemer, “Regional brain glucose metabolism and blood flow in streptozocin-induced diabetic rats,” Diabetes, vol. 39, no. 4, pp. 437–440, 1990. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Chen, X. Jiang, X. Zhao et al., “Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: a cross-section study,” Annals of Endocrinology, vol. 73, no. 3, pp. 208–212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Vikarunnessa, M. F. Weiner, and G. L. Vega, “LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 36, no. 3, pp. 571–575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Chaudhary, A. Likidlilid, T. Peerapatdit et al., “Apolipoprotein E gene polymorphism: Effects on plasma lipids and risk of type 2 diabetes and coronary artery disease,” Cardiovascular Diabetology, vol. 11, article no. 36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. M. A. Beydoun, L. L. Beason-Held, M. H. Kitner-Triolo et al., “Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment,” Journal of Epidemiology and Community Health, vol. 65, no. 11, pp. 949–957, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Cramer, M. N. Haan, S. Galea, K. M. Langa, and J. D. Kalbfleisch, “Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study,” Neurology, vol. 71, no. 5, pp. 344–350, 2008. View at Publisher · View at Google Scholar · View at Scopus